KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Accumulated Expenses (2016 - 2025)

Resmed's Accumulated Expenses history spans 16 years, with the latest figure at $391.5 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 11.05% year-over-year to $391.5 million; the TTM value through Dec 2025 reached $391.5 million, up 11.05%, while the annual FY2025 figure was $402.3 million, 6.51% up from the prior year.
  • Accumulated Expenses reached $391.5 million in Q4 2025 per RMD's latest filing, down from $395.8 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $402.3 million in Q2 2025 to a low of $274.1 million in Q3 2021.
  • Average Accumulated Expenses over 5 years is $345.7 million, with a median of $347.8 million recorded in 2023.
  • The largest YoY upside for Accumulated Expenses was 3756.6% in 2021 against a maximum downside of 1.57% in 2021.
  • A 5-year view of Accumulated Expenses shows it stood at $286.8 million in 2021, then increased by 8.84% to $312.2 million in 2022, then increased by 6.4% to $332.1 million in 2023, then increased by 6.14% to $352.5 million in 2024, then increased by 11.05% to $391.5 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Accumulated Expenses are $391.5 million (Q4 2025), $395.8 million (Q3 2025), and $402.3 million (Q2 2025).